General Surgery Coding Alert - 2004 Issue 35
Enforcement Watch: Pharmacy Takes Cover In Recycled Drug Loophole
Subscribe or sign in to view the full article.
Article Overview
This article reviews a federal appeals court decision involving a New Jersey provider-pharmacy and a Medicaid-related false-claims allegation tied to returned medications and claim credits. It is relevant to compliance, pharmacy operations, and healthcare legal professionals who follow Medicaid billing oversight, state regulatory gaps, and enforcement trends affecting repackaged or redispensed drugs.
Why This Topic Matters
The article highlights how missing or unclear state regulation can affect liability in Medicaid billing disputes and can influence pharmacy compliance practices, audit risk, and enforcement strategy.
What You Will Learn
- The general background of a pharmacy-related False Claims Act dispute
- How a court evaluated the absence of state regulatory guidance
- Why Medicaid billing and pharmacy compliance issues can become litigation risks
- How appellate decisions can shape enforcement expectations for recycled or returned medications
Who Should Read This
- Medical coders
- Billing and reimbursement professionals
- Pharmacy compliance staff
- Healthcare attorneys
- Compliance officers
- Revenue cycle teams
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com